Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Total HLA Class I Antigen Loss with the Downregulation of Antigen-Processing Machinery Components in Two Newly Established Sarcomatoid Hepatocellular Carcinoma Cell Lines.

Lei WY, Hsiung SC, Wen SH, Hsieh CH, Chen CL, Wallace CG, Chang CC, Liao SK.

J Immunol Res. 2018 Dec 16;2018:8363265. doi: 10.1155/2018/8363265. eCollection 2018.

2.

Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding beta2-microglobulin genes.

Hsieh CH, Hsu YJ, Chang CC, Liu HC, Chuang KL, Chuang CK, Pang ST, Hasumi K, Ferrone S, Liao SK.

Cancer Immunol Immunother. 2009 Mar;58(3):395-408. doi: 10.1007/s00262-008-0565-7. Epub 2008 Aug 15.

4.

Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.

Romero JM, Jiménez P, Cabrera T, Cózar JM, Pedrinaci S, Tallada M, Garrido F, Ruiz-Cabello F.

Int J Cancer. 2005 Feb 10;113(4):605-10.

5.

Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer.

Seliger B, Stoehr R, Handke D, Mueller A, Ferrone S, Wullich B, Tannapfel A, Hofstaedter F, Hartmann A.

Cancer Immunol Immunother. 2010 Apr;59(4):529-40. doi: 10.1007/s00262-009-0769-5. Epub 2009 Oct 7.

6.

Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?

Atkins D, Ferrone S, Schmahl GE, Störkel S, Seliger B.

J Urol. 2004 Feb;171(2 Pt 1):885-9.

PMID:
14713847
7.

Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.

Martayan A, Sibilio L, Tremante E, Lo Monaco E, Mulder A, Fruci D, Cova A, Rivoltini L, Giacomini P.

J Immunol. 2009 Mar 15;182(6):3609-17. doi: 10.4049/jimmunol.0802316.

8.

Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition.

Del Campo AB, Carretero J, Muñoz JA, Zinchenko S, Ruiz-Cabello F, González-Aseguinolaza G, Garrido F, Aptsiauri N.

Cancer Gene Ther. 2014 Aug;21(8):317-32. doi: 10.1038/cgt.2014.32. Epub 2014 Jun 27.

PMID:
24971583
9.

Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.

Facoetti A, Nano R, Zelini P, Morbini P, Benericetti E, Ceroni M, Campoli M, Ferrone S.

Clin Cancer Res. 2005 Dec 1;11(23):8304-11.

10.

Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.

Meissner M, Reichert TE, Kunkel M, Gooding W, Whiteside TL, Ferrone S, Seliger B.

Clin Cancer Res. 2005 Apr 1;11(7):2552-60.

11.

Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients.

Tanaka K, Tsuchikawa T, Miyamoto M, Maki T, Ichinokawa M, Kubota KC, Shichinohe T, Hirano S, Ferrone S, Dosaka-Akita H, Matsuno Y, Kondo S.

Int J Oncol. 2012 Apr;40(4):965-74. doi: 10.3892/ijo.2011.1274. Epub 2011 Nov 30.

12.

Association of IFN-gamma signal transduction defects with impaired HLA class I antigen processing in melanoma cell lines.

Respa A, Bukur J, Ferrone S, Pawelec G, Zhao Y, Wang E, Marincola FM, Seliger B.

Clin Cancer Res. 2011 May 1;17(9):2668-78. doi: 10.1158/1078-0432.CCR-10-2114. Epub 2011 Jan 19.

13.

HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.

Han LY, Fletcher MS, Urbauer DL, Mueller P, Landen CN, Kamat AA, Lin YG, Merritt WM, Spannuth WA, Deavers MT, De Geest K, Gershenson DM, Lutgendorf SK, Ferrone S, Sood AK.

Clin Cancer Res. 2008 Jun 1;14(11):3372-9. doi: 10.1158/1078-0432.CCR-07-4433.

15.

HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma.

Thuring C, Follin E, Geironson L, Freyhult E, Junghans V, Harndahl M, Buus S, Paulsson KM.

Br J Cancer. 2015 Sep 15;113(6):952-62. doi: 10.1038/bjc.2015.297. Epub 2015 Aug 27. Erratum in: Br J Cancer. 2015 Dec 1;113(11):1640.

16.

Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma.

Ritter C, Fan K, Paschen A, Reker Hardrup S, Ferrone S, Nghiem P, Ugurel S, Schrama D, Becker JC.

Sci Rep. 2017 May 23;7(1):2290. doi: 10.1038/s41598-017-02608-0.

17.

Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma.

Raffaghello L, Nozza P, Morandi F, Camoriano M, Wang X, Garrè ML, Cama A, Basso G, Ferrone S, Gambini C, Pistoia V.

Cancer Res. 2007 Jun 1;67(11):5471-8.

19.

WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?

Mehling M, Simon P, Mittelbronn M, Meyermann R, Ferrone S, Weller M, Wiendl H.

Acta Neuropathol. 2007 Aug;114(2):111-9. Epub 2007 May 31.

PMID:
17541610
20.

Defective HLA class I antigen processing machinery in cancer.

Cai L, Michelakos T, Yamada T, Fan S, Wang X, Schwab JH, Ferrone CR, Ferrone S.

Cancer Immunol Immunother. 2018 Jun;67(6):999-1009. doi: 10.1007/s00262-018-2131-2. Epub 2018 Feb 27.

PMID:
29487978

Supplemental Content

Support Center